Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 14-Jun-2022 titled Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market
Press Release Jun 14 2022
Filed with NSE · · 2 pages · English
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings CallRelease
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Jun 09 2022
- Press Release May 27 2022
- Press Release May 24 2022
- Press Release May 11 2022
- Press Release Apr 20 2022
Later from Dr. Reddy's Laboratories
- Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
- Press Release Jun 24 2022
- Press Release Jun 28 2022
- Press Release Jul 08 2022
- Press Release Jul 22 2022
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories